Inventor · disambiguated record
Martin Bolli
Also filed as: BOLLI MARTIN
65 granted patents·8 pending applications·597 citations·filing 2000–2025
99Inventor score
Files withACTELION PHARMACEUTICALS LTD27IDORSIA PHARMACEUTICALS LTD20BOLLI MARTIN18BINKERT CHRISTOPH4ABELE STEFAN2
Top patents by PatentIndex Score
73 records- 0196US11680058B2Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentanIDORSIA PHARMACEUTICALS LTD·Filed 2021·Granted Jun 20, 2023·5 cites·21 claims
- 0295USRE43833EThiazolidin-4-one derivativesBINKERT CHRISTOPH·Filed 2011·Granted Nov 27, 2012·21 cites·24 claims
- 0395US8273779B2Thiazolidin 4-one derivativesBINKERT CHRISTOPH·Filed 2009·Granted Sep 25, 2012·26 cites·19 claims
- 0495US7875726B2Thiazolidin-4-one derivativesACTELION PHARMACEUTICALS LTD·Filed 2008·Granted Jan 25, 2011·24 cites·7 claims
- 0594US8524752B2Thiazolidin-4-one derivativesBINKERT CHRISTOPH·Filed 2012·Granted Sep 3, 2013·22 cites·19 claims
- 0694US7626037B2Thiazolidin-4-one derivativesACTELION PHARMACEUTICALS LTD·Filed 2008·Granted Dec 1, 2009·24 cites·24 claims
- 0794US7285549B2Sulfamides and their use as endothelin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2006·Granted Oct 23, 2007·27 cites·5 claims
- 0893US11787782B2Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseasesIDORSIA PHARMACEUTICALS LTD·Filed 2021·Granted Oct 17, 2023·5 cites·39 claims
- 0993US8912340B2Process for the preparation of 2-imino-thiazolidin-4-one derivativesABELE STEFAN·Filed 2012·Granted Dec 16, 2014·16 cites·19 claims
- 1093USRE45174EThiazolidin-4-one derivativesACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Sep 30, 2014·14 cites·8 claims
- 1192US7435828B2Thiazolidin-4-one derivativesACTELION PHARMACEUTICALS LTD·Filed 2004·Granted Oct 14, 2008·33 cites·27 claims
- 1291US8263780B2Process for the preparation of 2-imino-thiazolidin-4-one derivativesABELE STEFAN·Filed 2007·Granted Sep 11, 2012·25 cites·4 claims
- 1391US7094781B2Sulfamides and their use as endothelin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2001·Granted Aug 22, 2006·38 cites·11 claims
- 1490USRE43728EThiazolidin-4-one derivativesBINKERT CHRISTOPH·Filed 2004·Granted Oct 9, 2012·25 cites·27 claims
- 1590US8003800B2Thiophene derivatives as S1P1/EDG1 receptor agonistsACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Aug 23, 2011·18 cites·29 claims
- 1690US7750040B2Thiophene derivativesACTELION PHARMACEUTICALS LTD·Filed 2005·Granted Jul 6, 2010·17 cites·16 claims
- 1790US7723378B2Hydrogenated benzo (C) thiophene derivatives as immunomodulatorsACTELION PHARMACEUTICALS LTD·Filed 2006·Granted May 25, 2010·16 cites·20 claims
- 1889US10919881B2Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentanIDORSIA PHARMACEUTICALS LTD·Filed 2018·Granted Feb 16, 2021·10 cites·24 claims
- 1989US8288554B2Pyridin-3-yl derivatives as immunomodulating agentsBOLLI MARTIN·Filed 2007·Granted Oct 16, 2012·15 cites·17 claims
- 2089US8133910B2Thiophene derivatives as S1P1/EDGE1 receptor agonistsBOLLI MARTIN·Filed 2007·Granted Mar 13, 2012·16 cites·21 claims
- 2189US7605269B2Thiophene derivatives as Sphingosine-1-phosphate-1 receptor agonistsACTELION PHARMACEUTICALS LTD·Filed 2006·Granted Oct 20, 2009·15 cites·17 claims
- 2288US8299086B2Pyrimidine derivativesBOLLI MARTIN·Filed 2008·Granted Oct 30, 2012·14 cites·13 claims
- 2388US8044076B2Phenyl derivatives and their use as immunomodulatorsACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Oct 25, 2011·13 cites·19 claims
- 2487US11174247B2Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseasesIDORSIA PHARMACEUTICALS LTD·Filed 2017·Granted Nov 16, 2021·6 cites·47 claims
- 2587US8178562B2Pyridine derivativesBOLLI MARTIN·Filed 2007·Granted May 15, 2012·10 cites·9 claims
- 2687US8148410B2Thiophene derivatives as agonists of S1P1/EDG1BOLLI MARTIN·Filed 2008·Granted Apr 3, 2012·11 cites·15 claims
- 2785US7981924B2Thiophene derivativesACTELION PHARMACEUTICALS LTD·Filed 2006·Granted Jul 19, 2011·8 cites·34 claims
- 2884US12297189B2Crystalline forms of a 4-pyrimidinesulfamide derivative aprocitentanIDORSIA PHARMACEUTICALS LTD·Filed 2023·Granted May 13, 2025·0 cites·25 claims
- 2984US9150566B22-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-YL)picolinamide derivatives as orexin receptor antagonistsBOLLI MARTIN·Filed 2012·Granted Oct 6, 2015·7 cites·27 claims
- 3084US8324232B24-pyrimidinesulfamide derivativeBOLLI MARTIN·Filed 2008·Granted Dec 4, 2012·13 cites·8 claims
- 3184US7951794B2Thiophene derivativesACTELION PHARMACEUTICALS LTD·Filed 2006·Granted May 31, 2011·9 cites·16 claims
- 3284US7846964B2Thiophene derivatives as spingosine-1-phosphate-1 receptor agonistsACTELION PHARMACEUTICALS LTD·Filed 2006·Granted Dec 7, 2010·11 cites·22 claims
- 3383US8598208B2Pyridine derivatives as S1P1/EDG1 receptor modulatorsBOLLI MARTIN·Filed 2008·Granted Dec 3, 2013·6 cites·8 claims
- 3483US8592460B2Amino-pyridine derivatives as S1P1 /EDG1 receptor agonistsBOLLI MARTIN·Filed 2008·Granted Nov 26, 2013·6 cites·14 claims
- 3583US8575200B2Pyridin-2-yl derivatives as immunomodulating agentsBOLLI MARTIN·Filed 2009·Granted Nov 5, 2013·6 cites·14 claims
- 3683US8410151B2Aminomethyl benzene derivativesBOLLI MARTIN·Filed 2009·Granted Apr 2, 2013·6 cites·10 claims
- 3782US12344597B2Alkoxy-substituted pyridinyl derivatives as LPA1 receptor antagonists and their use in the treatment of fibrosisIDORSIA PHARMACEUTICALS LTD·Filed 2019·Granted Jul 1, 2025·2 cites·21 claims
- 3882US9493446B2Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivativesACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Nov 15, 2016·6 cites·21 claims
- 3982US8658675B2Pyridin-4-yl derivativesBOLLI MARTIN·Filed 2010·Granted Feb 25, 2014·7 cites·45 claims
- 4082US8580824B2Pyridin-4-yl derivatives as immunomodulating agentsBOLLI MARTIN·Filed 2007·Granted Nov 12, 2013·6 cites·18 claims
- 4181US7868012B2Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseasesACTELION PHARMACEUTICALS LTD·Filed 2005·Granted Jan 11, 2011·4 cites·13 claims
- 4280US9617250B2Pyridin-4-yl derivativesACTELION PHARMACEUTICALS LTD·Filed 2014·Granted Apr 11, 2017·4 cites·11 claims
- 4380US8697732B2Pyridine derivativesBOLLI MARTIN·Filed 2012·Granted Apr 15, 2014·4 cites·10 claims
- 4479US9133179B22-methoxy-pyridin-4-yl-derivativesBOLLI MARTIN·Filed 2012·Granted Sep 15, 2015·5 cites·23 claims
- 4579US8039644B2Hydrogenated benzo (C) thiophene derivatives as immunomodulatorsACTELION PHARMACEUTICALS LTD·Filed 2010·Granted Oct 18, 2011·4 cites·20 claims
- 4678US12144811B2Combination of a 4-pyrimidinesulfamide derivative with an SGLT-2 inhibitor for the treatment of endothelin related diseasesIDORSIA PHARMACEUTICALS LTD·Filed 2018·Granted Nov 19, 2024·1 cites·31 claims
- 4772US7452896B2Pyrimidine-sulfamides and their use as endothelian receptor antagonistACTELION PHARMACEUTICALS LTD·Filed 2003·Granted Nov 18, 2008·5 cites·13 claims
- 4872US2025257056A1Alpha-d-galactopyranoside derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2025·Application pending·0 cites
- 4968US9403813B2Azetidine amide derivatives as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2014·Granted Aug 2, 2016·1 cites·12 claims
- 5068US9303023B2Pyrazole and imidazole derivatives useful as orexin antagonistsBOLLI MARTIN·Filed 2012·Granted Apr 5, 2016·1 cites·12 claims
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Martin Bolli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →